IR信息Denka Reveals "Denka Value-Up", a New Management Plan to Be Implemented from Fiscal 2018 to Fiscal 2022 with the Aim of Recreating Itself as a Specialty-Fusion Company

IR信息FY2017 First Half Summary of Consolidated Financial Results

IR信息FY2017 First Half Summary of Consolidated Financial Statements

IR信息FY2017 First Quarter Summary of Consolidated Financial Results

IR信息FY2017 First Quarter Summary of Consolidated Financial Statements

CSR信息Report on Third-Party Verification of Denka's GHG Emissions Data

CSR信息The Denka Group's Materiality Issues

IR信息The Denka Group Donates Ebola Virus Rapid Diagnostic Test Kits to the Democratic Republic of the Congo

IR信息FY2016 Summary of Consolidated Financial Results

IR信息FY2016 Summary of Consolidated Financial Statements

信息Progress in Obtaining U.S. FDA Approval for a Diagnostic Reagent for the Measurement of Heart Disease Risk Marker sd LDL-C and in the Denka Group’s Key Life Innovation Business

信息Notice of establishment New Company, Denka-KEW Genomics

信息Price revision for Denka Poval (Denka PVA)

信息Notice regarding the Construction of a New Hydroelectric Power Plant to Be Operated by Kurobegawa Electric Power

信息Opening Ceremony for Denka Life Innovation Research

IR信息Notice regarding Changes in Representative Directors at Denka Seiken

IR信息Notice regarding Changes in Representative Directors and Other Directors as well as Executive Officers

IR信息FY2016 Third Quarter Summary of Consolidated Financial Results

IR信息FY2016 Third Quarter Summary of Consolidated Financial Statements

信息新年致辞